Attached files

file filename
EX-10.1 - EX-10.1 - Oak Street Health, Inc.d99031dex101.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 2, 2020

 

 

Oak Street Health, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39427   84-3446686

(State or other jurisdiction of

incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification Number)

30 W. Monroe Street

Suite 1200

Chicago, Illinois 60603

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 733-9730

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   OSH   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement

On October 2, 2020, Oak Street Health, Inc. (the “Company”) awarded independent director Kim Keck 70,000 restricted stock units in connection with Ms. Keck’s services on the Company’s Board of Directors, contingent upon obtaining shareholder approval of the award at the Company’s next annual meeting of shareholders. The restricted stock units are subject to vesting as described in the Restricted Stock Unit Award Agreement attached hereto as Exhibit 10.1. If approved by the Company’s shareholders, upon vesting, the restricted stock units will be settled by issuing 70,000 shares of the Company’s common stock, par value $0.001 per share to Ms. Keck.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

  

Description

10.1    Restricted Stock Unit Award Agreement with Kim Keck dated October 1, 2020.

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: October 2, 2020

 

Oak Street Health, Inc.
By:   /s/ Michael Pykosz

Name:

Title:

 

Michael Pykosz

Chief Executive Officer

 

3